Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Statistics in Medicine
|
September 3, 2002
Bias in risk estimation: application to Down's syndrome screening
K L Williams, A B J Nix
Cytopathology : Official Journal of the British Society for Clinical Cytology
|
August 2, 2006
A comparison of variability in Papanicolaou and liquid-based cytology inadequacy rates using Shewhart control charts
R Fox, A B J Nix, H Fielder
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
August 9, 2003
Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?
K Spencer, R Bindra, A B J Nix, et al.
Annals of Clinical Biochemistry
|
February 5, 2003
Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy
K Spencer, J A Crossley, D A Aitken, et al.
Annals of Clinical Biochemistry
|
June 14, 2003
The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome
K Spencer, J A Crossley, D A Aitken, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Statistics in Medicine
|
September 3, 2002
Bias in risk estimation: application to Down's syndrome screening
K L Williams, A B J Nix
Cytopathology : Official Journal of the British Society for Clinical Cytology
|
August 2, 2006
A comparison of variability in Papanicolaou and liquid-based cytology inadequacy rates using Shewhart control charts
R Fox, A B J Nix, H Fielder
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
August 9, 2003
Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?
K Spencer, R Bindra, A B J Nix, et al.
Annals of Clinical Biochemistry
|
February 5, 2003
Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy
K Spencer, J A Crossley, D A Aitken, et al.
Annals of Clinical Biochemistry
|
June 14, 2003
The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome
K Spencer, J A Crossley, D A Aitken, et al.
Page
of 1